International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.

ABSTRACT:

Background and objectives

Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population.

Patients and methods

The Global Allergy and Asthma Excellence Network (GA²LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.

Results

103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamin

SUBMITTER: Pereira MP 

PROVIDER: S-EPMC12435135 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature